PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26364610-3	2016	Since the HSP90 inhibitor 17-allylamino-demethoxygeldanamycin (17AAG) is developed in clinics, we explored here its ability to control intestinal acute GvHD in vivo in two mouse GvHD models (C57BL/6 BALB/c and FVB/N Lgr5-eGFP), ex vivo in intestine organoids and in vitro in intestinal epithelial cultures.	17-allylamino-demethoxygeldanamycin	26-61	leucine rich repeat containing G protein coupled receptor 5	Mus musculus	216-220